Transjugular Intrahepatic Portosystemic Shunt

Transjugular Intrahepatic Portosystemic Shunt

Transjugular Intrahepatic Portosystemic Shunt

On this page

TIPS Basics - Shuntastic Voyage

  • Definition: A radiologically created shunt connecting the portal vein (PV) to a hepatic vein (HV) through the liver parenchyma.
  • Access: Typically via the right internal jugular vein.
  • Mechanism: A stent-graft is placed, creating a low-resistance pathway for portal blood to bypass the cirrhotic liver, directly entering systemic circulation.
  • Goal: ↓ Portal pressure, alleviating complications of portal hypertension.
  • Key Effect: Reduces portosystemic gradient (PSG). Diagram of TIPS stent connecting portal and hepatic veins

⭐ Successful TIPS typically reduces the portosystemic gradient (PSG) to below 12 mmHg or by at least 50% from baseline to effectively manage variceal bleeding risk and refractory ascites.

The TIPS Procedure - Navigating the Liver

  • Access Route: Right Internal Jugular Vein (Rt. IJV) preferred → Superior Vena Cava (SVC) → Right Atrium (RA) → Inferior Vena Cava (IVC) → Hepatic Vein (HV), typically Right HV.
  • Guidance & Initial Steps: Fluoroscopy (primary); Ultrasound (IJV access). Wedged hepatic venography & portography (visualize Portal Vein).
  • Parenchymal Puncture: From HV, advance needle (e.g., Colapinto) anteriorly/medially into intrahepatic Portal Vein (PV) branch. Confirm PV access.
  • Shunt Creation & Stenting: Guidewire into PV (e.g., Superior Mesenteric Vein/Splenic Vein). Dilate tract (8-10 mm balloon). Deploy covered stent-graft (PTFE) from PV to HV.
  • Hemodynamic Goal: Target Portosystemic Gradient (PSG) < 12 mmHg or ≥50% reduction from baseline.

⭐ Covered stents (e.g., Viatorr) significantly improve primary patency by reducing bile duct injury and intimal hyperplasia compared to bare metal stents.

TIPS Hurdles - Shunt Shenanigans

Contraindications (CI): ⚠️

  • Absolute:
    • CHF, severe pulm HTN (mPAP > 45 mmHg)
    • Severe tricuspid regurgitation
    • Polycystic liver disease (extensive)
    • Uncontrolled sepsis/infection
    • Unrelieved biliary obstruction
  • Relative:
    • Active HCC
    • Severe coagulopathy (INR > 5, Plt < 20k), uncorrectable
    • Central tumors obstructing IVC/hepatic veins

Complications:

  • Early (< 30 days):
    • HE (most common, ~30-50%)
    • Hemorrhage (capsular/intraperitoneal), neck hematoma
    • Stent issues: malposition, migration, infection, thrombosis
    • Acute liver failure, hemolysis
  • Late (> 30 days):
    • Shunt stenosis/occlusion (common late)
    • Worsening/refractory HE
    • Progressive liver failure

Shunt Dysfunction:

  • Causes:
    • Neointimal hyperplasia (commonest for stenosis)
    • Thrombosis (acute/chronic)
    • Stent migration or kinking
  • Sx: Recurrent ascites, variceal bleed
  • Dx: Doppler US (flow changes), portography

⭐ > New or worsening hepatic encephalopathy: most common post-TIPS complication, affects up to 50%.

Risk factors for post-TIPS hepatic encephalopathy

TIPS Check-up - Shunt Surveillance

  • Goal: Maintain shunt patency & prevent complications (e.g., hepatic encephalopathy, shunt stenosis/occlusion).
  • Initial Check: Doppler Ultrasound (DUS) within 24-72 hours post-TIPS.
  • Routine Surveillance (DUS):
    • At 1, 3, 6 months post-procedure.
    • Then every 6-12 months lifelong.
  • Key Parameters Assessed:
    • Shunt patency and morphology.
    • Peak Shunt Velocity (PSV): Normal range 90-190 cm/s.
  • Signs of Dysfunction on DUS:
    • PSV < 90 cm/s or > 190 cm/s.
    • Significant PSV change from baseline (e.g., ↑ > 50% or ↓ > 40%).
    • Focal velocity ↑ (stenosis); no flow (occlusion).
    • Clinical: Recurrence of ascites or variceal bleeding.

⭐ Doppler ultrasound is the primary non-invasive modality for routine TIPS surveillance, assessing flow velocities and identifying stenosis or occlusion. Doppler ultrasound and CT of TIPS

  • Management of Dysfunction: Confirm with portography/venography & pressure measurements; consider angioplasty, re-stenting, or parallel TIPS if indicated.

High‑Yield Points - ⚡ Biggest Takeaways

  • TIPS: Shunt between hepatic vein (e.g., RHV) and portal vein (e.g., RPV) via stent.
  • Primary indications: Refractory variceal hemorrhage and refractory ascites.
  • Most common significant complication: New or worsening hepatic encephalopathy.
  • Key contraindications: Severe heart failure (NYHA III/IV), severe pulmonary hypertension, uncontrolled systemic infection.
  • Doppler ultrasound is primary for monitoring shunt patency.
  • Therapeutic goal: ↓ Portosystemic gradient (PSG) to <12 mmHg or by >50%.
  • Covered stents preferred over bare stents for ↑ long-term patency.

Practice Questions: Transjugular Intrahepatic Portosystemic Shunt

Test your understanding with these related questions

The ideal muscle relaxant used for a neonate undergoing porto-enterostomy for biliary atresia is:

1 of 5

Flashcards: Transjugular Intrahepatic Portosystemic Shunt

1/9

A carotid cavernous fistula requires a definitive treatment, which currently involves the _____ technique using a balloon or coil

TAP TO REVEAL ANSWER

A carotid cavernous fistula requires a definitive treatment, which currently involves the _____ technique using a balloon or coil

endovascular

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial